Medical research is an important part of the UK research landscape. The Government recognises this and already provides significant support within the tax system, the research funding system and through the many measures that have been introduced to counter the impacts of the pandemic.
Despite the fiscal challenges, the Government has set out plans at Spending Review to cement the UK’s status as a global leader in science and innovation by investing £14.6 billion in R&D in 2021/22. Departments will now undertake an allocations process to decide how this funding should be spent across the R&D activities for which they are responsible. Funding for medical research will be subject to this allocations process and further details of how funding will be allocated will be announced in due course.